Evaluating the concordance between BICLA and SRI4 in patients with systemic lupus erythematosus from the placebo arms of the EXPLORER and ATHOS trials.

Saved in:
Bibliographic Details
Title: Evaluating the concordance between BICLA and SRI4 in patients with systemic lupus erythematosus from the placebo arms of the EXPLORER and ATHOS trials.
Authors: Askanase AD; Columbia University Irving Medical Center, New York University, New York City, New York, USA., Vital EM; University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, UK.; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Meier O; F. Hoffmann-La Roche Ltd, Basel, Switzerland oliver.meier.om2@roche.com., Turchetta A; Hoffmann-La Roche Ltd, Mississauga, Ontario, Canada., Mao HA; Hoffmann-La Roche Ltd, Mississauga, Ontario, Canada., Maller J; Genentech, Inc, South San Francisco, California, USA., Ross Terres JA; Genentech, Inc, South San Francisco, California, USA., Dall'Era M; University of California San Francisco, San Francisco, California, USA.
Source: Lupus science & medicine [Lupus Sci Med] 2025 May 19; Vol. 12 (1). Date of Electronic Publication: 2025 May 19.
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: BMJ Country of Publication: England NLM ID: 101633705 Publication Model: Electronic Cited Medium: Print ISSN: 2053-8790 (Print) Linking ISSN: 20538790 NLM ISO Abbreviation: Lupus Sci Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40389370
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluating the concordance between BICLA and SRI4 in patients with systemic lupus erythematosus from the placebo arms of the EXPLORER and ATHOS trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Askanase+AD%22">Askanase AD</searchLink>; Columbia University Irving Medical Center, New York University, New York City, New York, USA.<br /><searchLink fieldCode="AU" term="%22Vital+EM%22">Vital EM</searchLink>; University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, UK.; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Meier+O%22">Meier O</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland oliver.meier.om2@roche.com.<br /><searchLink fieldCode="AU" term="%22Turchetta+A%22">Turchetta A</searchLink>; Hoffmann-La Roche Ltd, Mississauga, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Mao+HA%22">Mao HA</searchLink>; Hoffmann-La Roche Ltd, Mississauga, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Maller+J%22">Maller J</searchLink>; Genentech, Inc, South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Ross+Terres+JA%22">Ross Terres JA</searchLink>; Genentech, Inc, South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Dall'Era+M%22">Dall'Era M</searchLink>; University of California San Francisco, San Francisco, California, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101633705%22">Lupus science & medicine</searchLink> [Lupus Sci Med] 2025 May 19; Vol. 12 (1). <i>Date of Electronic Publication: </i>2025 May 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ%22">BMJ </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101633705 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2053-8790 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220538790%22">20538790 </searchLink><i>NLM ISO Abbreviation: </i>Lupus Sci Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40389370
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/lupus-2024-001483
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Evaluating the concordance between BICLA and SRI4 in patients with systemic lupus erythematosus from the placebo arms of the EXPLORER and ATHOS trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Askanase AD
      – PersonEntity:
          Name:
            NameFull: Vital EM
      – PersonEntity:
          Name:
            NameFull: Meier O
      – PersonEntity:
          Name:
            NameFull: Turchetta A
      – PersonEntity:
          Name:
            NameFull: Mao HA
      – PersonEntity:
          Name:
            NameFull: Maller J
      – PersonEntity:
          Name:
            NameFull: Ross Terres JA
      – PersonEntity:
          Name:
            NameFull: Dall'Era M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 05
              Text: 2025 May 19
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2053-8790
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Lupus science & medicine
              Type: main
ResultId 1